Pfizer, Inc. · NYSE:PFE
Pfizer — Fact Sheet (August 2024)
7 slides from Pfizer's fact sheet, August 2024
Slide 1: Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) Presentation and Dosing Guide
Intended for U.S. Healthcare Professionals Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) Presentation and Dosing Guide Individuals 6 Months Through 11 Years of Age Emergency Use Authorization (EUA) Emergency uses of COVID-19 vaccines from BioNTech and Pfizer, including Pfizer-BioNTech COVID-1
Slide 2: Identifying vials of Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula)
Vaccine Presentation and Dosing Guide Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) For eligible individuals 6 months through 11 years of age Identifying vials of Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) Verify the vials (including labels) prior to preparation for administration t
Slide 3: Vaccine Presentation and Dosing Guide: dose, dilution and storage
Vaccine Presentation and Dosing Guide Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) For eligible individuals 6 months through 11 years of age Verify the vials (including labels) prior to preparation for administration to help avoid vaccine administration errors Pfizer-BioNTech COVID-19 Vaccin
Slide 4: Dosing schedule by vaccination status
Vaccine Presentation and Dosing Guide Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) For eligible individuals 6 months through 11 years of age Individuals 6 Months Through 4 Years of Age Individuals 5 Through 11 Years of Age Pfizer-BioNTech COVID-19 Vaccination Status1: Irrespective of COVID-1
Slide 5: Individuals 6 Months Through 11 Years of Age With Certain Kinds of Immunocompromise
Vaccine Presentation and Dosing Guide Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) For eligible individuals 6 months through 11 years of age Individuals 6 Months Through 11 Years of Age With Certain Kinds of Immunocompromise Individuals 6 months through 11 years of age with certain kinds of
Slide 6: Important Safety Information and Authorized Use
Important Safety Information and Authorized Use for Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) IMPORTANT SAFETY INFORMATION Do not administer Pfizer-BioNTech COVID-19 Vaccine to individuals with a Adverse Reactions history of a severe allergic reaction (e.g., anaphylaxis) to any component
Slide 7: Find additional resources at www.cvdvaccine-us.com
Find additional resources about Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) at: www.cvdvaccine-us.com PP-CVV-USA-4490 7 of 7 © 2024 Pfizer Inc. All rights reserved. August 2024